InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Farrow Jeffrey S, Chief Financial Officer. Director active across 2 companies, notably Global Blood Therapeutics, Inc.. In total, 15 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €182k. History available since 27 September 2022. The latest transaction was disclosed on 17 March 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Farrow Jeffrey S
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations15 total
2,111 shares@ US$69.4270.1% of flowCommon StockSEC:0001405253-26-000007:0
13,042 sharesCommon StockSEC:0001405253-26-000005:0
27,881 sharesCommon StockSEC:0001819790-25-000102:0
1,284 shares@ US$46.29100.0% of flowCommon StockSEC:0001819790-25-000054:0
8,019 sharesCommon StockSEC:0001819790-25-000047:0
27,881 sharesCommon StockSEC:0001819790-24-000089:0
26,739 sharesCommon StockSEC:0000899243-22-033145:0
23,653 shares@ US$16.40100.0% of flowCommon StockSEC:0000899243-22-032265:0
2,763 sharesCommon StockSEC:0000899243-22-030475:0
6,145 sharesCommon StockSEC:0000899243-22-027634:0
2,763 sharesCommon StockSEC:0000899243-22-009239:0
9,020 sharesCommon StockSEC:0000899243-22-004639:0
9,020 sharesCommon StockSEC:0000899243-21-037668:0
2,762 sharesCommon StockSEC:0000899243-21-035221:0
9,020 sharesCommon StockSEC:0000899243-21-031353:0
15 of 15 declarations
About Farrow Jeffrey S
Farrow Jeffrey S is Chief Financial Officer. The declarant has 15 filings in total, and in the sampled recent filings from 2021-08-03 to 2026-03-19, the most frequent transaction nature is option exercise, with 0 in buys and 181869 in sells. The companies mentioned are Global Blood Therapeutics, Inc. and Tarsus Pharmaceuticals, Inc.
